260 related articles for article (PubMed ID: 25187919)
1. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
[TBL] [Abstract][Full Text] [Related]
2. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Jan; ():. PubMed ID: 25227594
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.
Li Z; Duan X; Hu Y; Zhou M; Liu M; Kang K; Cai H; Yi W; Fu D; Gao X
Biomed Res Int; 2020; 2020():1374276. PubMed ID: 32420317
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
[TBL] [Abstract][Full Text] [Related]
5. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir.
Park H; Park JY; Kim SU; Kim DY; Han KH; Chon CY; Ahn SH
World J Gastroenterol; 2013; 19(43):7671-9. PubMed ID: 24431895
[TBL] [Abstract][Full Text] [Related]
7. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
Jiang HX; Han GR; Wang CM; Ji Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
[TBL] [Abstract][Full Text] [Related]
9. Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up.
Yi W; Cao X; Zeng Z; Cao W; Zhang Y; Sun F; Wang Y; Wan G; Li M; Xie Y
Virulence; 2021 Dec; 12(1):1527-1537. PubMed ID: 34120564
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
Li Z; Xie B; Yi N; Cai H; Yi W; Gao X
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():102-106. PubMed ID: 35853269
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.
Sheng Q; Ding Y; Li B; Han C; Li Y; Zhang C; Bai H; Wang J; Zhao L; Xia T; An Z; Zhang M; Dou X
Int J Med Sci; 2018; 15(8):796-801. PubMed ID: 30008589
[No Abstract] [Full Text] [Related]
12. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
[TBL] [Abstract][Full Text] [Related]
13. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.
Pan CQ; Han GR; Jiang HX; Zhao W; Cao MK; Wang CM; Yue X; Wang GJ
Clin Gastroenterol Hepatol; 2012 May; 10(5):520-6. PubMed ID: 22343511
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
15. Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B.
Pan CQ; Yi W; Liu M; Wan G; Hu YH; Zhou MF
J Viral Hepat; 2017 Mar; 24(3):246-252. PubMed ID: 28025872
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
[TBL] [Abstract][Full Text] [Related]
17. Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy.
Liu M; Cai H; Yi W
J Viral Hepat; 2013 Apr; 20 Suppl 1():65-70. PubMed ID: 23458527
[TBL] [Abstract][Full Text] [Related]
18. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Jiang HX; Yue X; Ding Y; Wang CM; Wang GJ; Yang YF
J Viral Hepat; 2015 Sep; 22(9):754-62. PubMed ID: 25641421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
